Mr. Derek Webb reports

BIOREM ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID

The TSX Venture Exchange has approved Biorem Inc.'s application to implement a normal course issuer bid (NCIB) for a portion of its common shares.

Biorem believes that: (1) the repurchase of common shares would be an effective use of its cash resources and in the best interests of Biorem and its shareholders; (2) the current market price of its common shares does not fully reflect their underlying value; and (3) current market conditions provide opportunities for the company to acquire common shares at attractive prices.

Pursuant to the NCIB notice filed with and accepted by the TSX-V, the company has been authorized to acquire up to a maximum of 806,872 common shares, or approximately 5 per cent of the currently issued and outstanding common shares as of June 10, 2025, for cancellation. As of June 10, 2025, Biorem had 16,137,437 common shares issued and outstanding and a public float of 15,235,000 common shares.

Purchases under the NCIB will commence on or about June 16, 2025, and will terminate on the earlier of: (i) one year from such commencement; or (ii) the date on which the company has purchased the maximum number of shares to be acquired under the NCIB. The NCIB will be conducted on behalf of the company by Cormark Securities Inc. The purchase and payment for the common shares will be made in accordance with TSX-V requirements at the market price of the common shares at the time of acquisition, plus brokerage fees, if any, charged by the broker. Purchases under the NCIB will be made in accordance with applicable regulatory requirements through the facilities of the TSX-V. All common shares purchased under the NCIB will be cancelled upon their purchase. The company intends to finance the purchases out of its available resources.

To the company's knowledge, none of the officers or other insiders of the company, or any associate of such person, or any associate of affiliate of the company, has any present intention to sell any shares to the company pursuant to the NCIB. The company has not purchased for cancellation any of its outstanding shares within the 12 months preceding the filing of the NCIB notice with the TSX-V.

About Biorem Inc.

Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odours, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network, and more than 2,000 installed systems worldwide, Biorem offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities.

We seek Safe Harbor.